Drawing for BP 3B PHARMACEUTICALS

USPTO serial 79231543

BP 3B PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 5699890Status 739Registered
Filing date
Status date
Registration date
Mar 19, 2019
Examiner
SINGH, TEJBIR
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with BP 3B PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Todd A. Sullivan

Todd A. Sullivan Hayes Soloway P.C.175 Canal StreetManchester, NH 03101United States

Goods and services

ClassDescriptionStatusFirst use
042Technological consultation and research in the field of chemical analysis; Analysis of industrial fluids; chemical analysis; biological research; research relating to biotechnology; research in the field of chemistry, biotechnology, pharmacy or pharmacology; research and development and research into new products for others, in particular new medicines or diagnostic preparations for others; research and development of drug candidates for medicines, in particular peptide medicines; research and development of chemical or biotechnological preparations for diagnostic preparations, in particular of chemical or biotechnological preparations for targeted molecular imaging; chemical, biotechnological or pharmacological surveys, in particular for research and development of drug candidates for medicines or research and development of biotechnological preparations for diagnostic preparations; research and development services for biotechnical manufacturing of medical or diagnostic products; in-vitro pharmacological analysis services for absorption, distribution, metabolism, and excretion of drug candidates * ; with the proviso that all the aforementioned services do not include biotechnological production of drug candidates or medicaments using (i) cell-based technologies and (ii) cell-free technologies in amounts larger than 10 mg *ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 18, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jun 18, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jun 18, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 10, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Mar 19, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 18, 2022INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jan 20, 2022INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 20, 2021LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
May 20, 2021COC.CORRECTION UNDER SECTION 7 - PROCESSED—
May 20, 2021PLGLASSIGNED TO PARALEGAL—
May 15, 2021LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jul 26, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 10, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 10, 2019FIMPFINAL DISPOSITION PROCESSED—
Jun 19, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 19, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 1, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 19, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 19, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 19, 2018ALIEASSIGNED TO LIE—
Nov 7, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 9, 2018RFNTREFUSAL PROCESSED BY IB—
May 18, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 18, 2018RFRRREFUSAL PROCESSED BY MPU—
May 18, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
May 15, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 14, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2018DOCKASSIGNED TO EXAMINER—
May 14, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 11, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
May 10, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance